Finoriq research workspace
Quanterix Corp (QTRX) SEC Filings & Filing Highlights
Quanterix Corp offers HD-X instrument, a protein detection platform; and SR-X instrument that. Review QTRX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
- Company
- Quanterix Corp (QTRX)
- Ticker
- QTRX
- Market Cap
- $183.2M
- Latest Price
- $3.89
- Industry
- Life Science Tools
Quanterix Corp (QTRX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Quanterix Corp (QTRX).
| Event | Form | Date |
|---|---|---|
| At the 2026 Annual Meeting of Stockholders of Quanterix Corporation (the “Company”) held on Jun...At the 2026 Annual Meeting of Stockholders of Quanterix Corporation (the “Company”) held on June 9, 2026 (the “Annual Meeting”), the stockh... | 8-K5.07 | 2026-06-10 |
| Quanterix Announces Appointment of Jason FaesslerQuanterix Announces Appointment of Jason Faessler | 8-K7.01 | 2026-06-09 |
| The Board of Directors of Quanterix Corporation (the “Company”) has appointed Jason Faessler as...The Board of Directors of Quanterix Corporation (the “Company”) has appointed Jason Faessler as the Chief Financial Officer and Treasurer o... | 8-K5.02 | 2026-06-09 |
| On May 14, 2026, Anthony Catalano was appointed as the Chief Operating Officer of Quanterix Cor...On May 14, 2026, Anthony Catalano was appointed as the Chief Operating Officer of Quanterix Corporation (the “Company”). Mr. Catalano mostl... | 8-K5.02 | 2026-05-26 |
| Quanterix Announces Planned Transition of Chief Financial OfficerQuanterix Announces Planned Transition of Chief Financial Officer | 8-K7.01 | 2026-05-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.